Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Princeton Blue is a private process automation and consulting company focused on pharmaceutical, biotech, and medical device customers rather than a therapeutics developer. The company provides low-code workflow and orchestration solutions for life sciences use cases spanning clinical operations, regulatory, lab, manufacturing, and drug safety. Its offerings are built largely around the Appian AI process platform and related technologies such as Data Fabric, case management, robotic process automation, and AI-enabled enterprise integrations with systems like Veeva, SAP, Oracle, and LIMS/ELN. Princeton Blue appears to operate as an active commercial services and software-enablement business with offices in the United States and India. For a biotech analyst, it is best categorized as a life-science-focused digital transformation and process automation vendor, not a drug pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Princeton Blue.